CAI Caris Life Sciences Inc.

$CAI Caris has a 9/10 growth outlook because it is expanding across several large, underpenetrated markets rather than relying on a single assay. The domestic addressable opportunity exceeds $100 billion annually, including approximately $10 billion for therapy selection, $20 billion for MRD and recurrence monitoring, and more than $70 billion for MCED. Therapy-selection penetration is only 35%, while blood-based monitoring remains early in adoption. Caris Detect launched commercially in July 2026 and targets 58 cancer types using ultra-deep WGS, WTS, and AI trained on more than one million real-world cases. Caris Assure volume grew 50% year over year in Q2 2026, and management is tripling laboratory capacity toward a $3.0 billion revenue run rate. The report models 15%–25% five-year revenue CAGR, with a base case of 18%, although commercial adoption, reimbursement, and operational scaling determine whether the upper end is achievable.

$CAI 18 SEP 26 $30 CALL $0.45 HIGH CONFIDENCE + RELATIVE STRENGTH + IPO PRICE BREAKOUT CONTINUATION + PRICE TARGET BY UBS

$CAI .. holy smokes! What a run this week over at Caris . I think we need one of their fancy Kevin Costner commercials over here at $LKNCY $RKLB $VELO and an especially ‘touching holiday version’ for my crippled lil tiny Tim ticker $BURU 💰😎👍

WHO WANTS ANOTHER HIGH-CONFIDENCE TRADE LIKE $CAI $30 CALLS THAT JUST HIT 100% IN LESS THAN ONE HOUR?! ☢️🔥 100%+ GAINER AFTER 100%+ GAINER — THE SETUPS SPEAK FOR THEMSELVES. 📈 I’LL KEEP POSTING THE SETUPS. YOU DECIDE IF THEY’RE FOR YOU NO PRESSURE, JUST REAL TRADES, REAL RESULTS, AND DISCIPLINE. ☢️ LIKE THIS IF YOU WANT THE NEXT ONE. 👀

$CAI look long-term easy new ATH in next Qs. DCA present we got for next run! i buy 50-100 next shares

🧬 $CAI — 100% GAINER $30 CALL | 18 SEP 26 $0.45 ➡️ $0.90 💰 That’s a clean 100% move from entry. 📈 Another setup executed with discipline. No chasing — just following the plan. ⚠️ Options are high-risk. Manage your position size and risk.